(LNN) Lindsay - Overview
Stock: Center Pivot, Lateral Move, Road Zipper, Crash Cushions, Variable Barriers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.13% |
| Yield on Cost 5y | 1.22% |
| Yield CAGR 5y | 2.75% |
| Payout Consistency | 99.5% |
| Payout Ratio | 21.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.0% |
| Relative Tail Risk | -9.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.09 |
| Alpha | -10.93 |
| Character TTM | |
|---|---|
| Beta | 0.771 |
| Beta Downside | 0.738 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.83% |
| CAGR/Max DD | -0.12 |
Description: LNN Lindsay January 16, 2026
Lindsay Corporation (NYSE:LNN) operates two distinct business lines: the Irrigation segment, which designs, manufactures, and services center-pivot and lateral-move irrigation equipment (Zimmatic, Perrot) along with advanced controls, sensors, and IoT solutions (Elecsys); and the Infrastructure segment, which supplies the Road Zipper System-T-shaped concrete/steel barriers, barrier-transfer machines, and crash-cushion products-for highway construction, widening, and safety applications, plus a suite of rail-related safety hardware.
Key quantitative points (FY 2023): total revenue of roughly $1.1 billion, with the Irrigation business contributing about 70 % and Infrastructure about 30 %; irrigation shipments grew ~8 % YoY, driven by heightened demand in drought-prone regions such as the U.S. Midwest. The segment’s recurring-revenue stream from parts, service contracts, and data-analytics subscriptions now exceeds 25 % of its total sales, providing a stabilizing cash flow. A primary macro driver is the U.S. federal infrastructure investment agenda, which has allocated over $550 billion to road and bridge projects, creating a tailwind for the Road Zipper product line. Conversely, the irrigation business is sensitive to commodity price cycles and weather variability, making precipitation forecasts and farm-equipment financing rates material risk factors.
For a deeper dive into LNN’s valuation metrics and scenario analysis, you might explore the company’s profile on ValueRay, where the platform aggregates real-time analyst estimates and peer-group benchmarks.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 73.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.75 > 1.0 |
| NWC/Revenue: 53.85% < 20% (prev 60.83%; Δ -6.99% < -1%) |
| CFO/TA 0.13 > 3% & CFO 110.7m > Net Income 73.4m |
| Net Debt (-63.7m) to EBITDA (116.3m): -0.55 < 3 |
| Current Ratio: 3.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.7m) vs 12m ago -1.87% < -2% |
| Gross Margin: 31.67% > 18% (prev 0.31%; Δ 3136 % > 0.5%) |
| Asset Turnover: 83.27% > 50% (prev 79.38%; Δ 3.89% > 0%) |
| Interest Coverage Ratio: 88.36 > 6 (EBITDA TTM 116.3m / Interest Expense TTM 1.08m) |
Altman Z'' 9.15
| A: 0.43 (Total Current Assets 507.0m - Total Current Liabilities 148.4m) / Total Assets 828.4m |
| B: 0.92 (Retained Earnings 758.0m / Total Assets 828.4m) |
| C: 0.12 (EBIT TTM 95.5m / Avg Total Assets 799.7m) |
| D: 2.41 (Book Value of Equity 746.4m / Total Liabilities 310.2m) |
| Altman-Z'' Score: 9.15 = AAA |
Beneish M -3.03
| DSRI: 0.98 (Receivables 129.0m/120.9m, Revenue 665.9m/612.0m) |
| GMI: 0.99 (GM 31.67% / 31.23%) |
| AQI: 1.02 (AQ_t 0.18 / AQ_t-1 0.18) |
| SGI: 1.09 (Revenue 665.9m / 612.0m) |
| TATA: -0.05 (NI 73.4m - CFO 110.7m) / TA 828.4m) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of LNN shares?
Over the past week, the price has changed by +5.31%, over one month by +5.84%, over three months by +20.64% and over the past year by +4.57%.
Is LNN a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LNN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 134 | -0% |
| Analysts Target Price | 134 | -0% |
| ValueRay Target Price | 144.9 | 8.1% |
LNN Fundamental Data Overview February 02, 2026
P/E Forward = 22.2222
P/S = 1.9926
P/B = 2.5267
P/EG = 1.1698
Revenue TTM = 665.9m USD
EBIT TTM = 95.5m USD
EBITDA TTM = 116.3m USD
Long Term Debt = 114.8m USD (from longTermDebt, last quarter)
Short Term Debt = 4.36m USD (from shortTermDebt, last quarter)
Debt = 135.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -63.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.26b USD (1.33b + Debt 135.9m - CCE 199.6m)
Interest Coverage Ratio = 88.36 (Ebit TTM 95.5m / Interest Expense TTM 1.08m)
EV/FCF = 20.09x (Enterprise Value 1.26b / FCF TTM 62.9m)
FCF Yield = 4.98% (FCF TTM 62.9m / Enterprise Value 1.26b)
FCF Margin = 9.44% (FCF TTM 62.9m / Revenue TTM 665.9m)
Net Margin = 11.02% (Net Income TTM 73.4m / Revenue TTM 665.9m)
Gross Margin = 31.67% ((Revenue TTM 665.9m - Cost of Revenue TTM 455.0m) / Revenue TTM)
Gross Margin QoQ = 32.15% (prev 29.11%)
Tobins Q-Ratio = 1.52 (Enterprise Value 1.26b / Total Assets 828.4m)
Interest Expense / Debt = 0.25% (Interest Expense 334.0k / Debt 135.9m)
Taxrate = 24.50% (5.36m / 21.9m)
NOPAT = 72.1m (EBIT 95.5m * (1 - 24.50%))
Current Ratio = 3.42 (Total Current Assets 507.0m / Total Current Liabilities 148.4m)
Debt / Equity = 0.26 (Debt 135.9m / totalStockholderEquity, last quarter 518.2m)
Debt / EBITDA = -0.55 (Net Debt -63.7m / EBITDA 116.3m)
Debt / FCF = -1.01 (Net Debt -63.7m / FCF TTM 62.9m)
Total Stockholder Equity = 524.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.18% (Net Income 73.4m / Total Assets 828.4m)
RoE = 14.01% (Net Income TTM 73.4m / Total Stockholder Equity 524.1m)
RoCE = 14.95% (EBIT 95.5m / Capital Employed (Equity 524.1m + L.T.Debt 114.8m))
RoIC = 11.28% (NOPAT 72.1m / Invested Capital 639.1m)
WACC = 7.96% (E(1.33b)/V(1.46b) * Re(8.76%) + D(135.9m)/V(1.46b) * Rd(0.25%) * (1-Tc(0.24)))
Discount Rate = 8.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.64%
[DCF Debug] Terminal Value 77.81% ; FCFF base≈63.5m ; Y1≈61.7m ; Y5≈61.7m
Fair Price DCF = 111.1 (EV 1.10b - Net Debt -63.7m = Equity 1.16b / Shares 10.5m; r=7.96% [WACC]; 5y FCF grow -3.92% → 2.90% )
EPS Correlation: -16.41 | EPS CAGR: 4.20% | SUE: 0.04 | # QB: 0
Revenue Correlation: -60.73 | Revenue CAGR: -6.46% | SUE: -1.03 | # QB: 0
EPS next Quarter (2026-05-31): EPS=1.87 | Chg30d=+0.080 | Revisions Net=+2 | Analysts=4
EPS current Year (2026-08-31): EPS=6.40 | Chg30d=+0.352 | Revisions Net=+3 | Growth EPS=-5.7% | Growth Revenue=-3.9%
EPS next Year (2027-08-31): EPS=6.79 | Chg30d=+0.003 | Revisions Net=-1 | Growth EPS=+6.2% | Growth Revenue=+6.5%